Traci

Trial Care International (TCI) is a specialized Contract Research Organization (CRO) that provides comprehensive clinical trial management and monitoring services to the pharmaceutical, biotechnology, and medical device industries. The company is particularly recognized for its deep expertise in imaging studies, specifically those involving radiopharmaceuticals and contrast agents. TCI supports the entire clinical development lifecycle, from Phase I through Phase IV, with a strong focus on therapeutic areas such as oncology, cardiology, and neurology. By integrating seasoned clinical professionals with specialized imaging knowledge, TCI acts as a seamless extension of its clients' project teams to accelerate the path to regulatory approval. The company has a proven track record of success, including its role as the monitoring CRO for the FDA-approved oncology agent AZEDRA.